We must ensure that all future health decisions are made with the best interests of all Americans in mind — not the financial motives of profit-seeking plaintiffs’ lawyers.
Robert F. Kennedy Jr., secretary-designate of Health and Human Services, is among President Donald Trump’s myriad unorthodox Cabinet picks to lead federal agencies. While his past science-skeptical positions, including views on vaccinations and fluoride in drinking water, garnered attention from medical professionals, Kennedy’s deep ties to the organized trial bar deserve equal examination.
As Kennedy faces Senate confirmation hearings, his past financial interests and work for profit-motivated personal injury law firms could impact his leadership and result in a more litigious HHS.
Kennedy previously was on the payroll of Morgan & Morgan, the nation’s largest personal injury firm, from 2016 to 2022 and remains co-counsel on contingency fee cases. He’s also worked closely with another prominent personal injury firm, Wisner Baum. Kennedy’s partnership with Wisner Baum includes litigation against Monsanto alleging its product, Roundup®, caused users to develop non-Hodgkin lymphoma, a theory widely rejected by much of the scientific community, as well as litigation against Merck regarding its Gardasil vaccine. He reported $856,559 in income from his work on these and other contingency fee cases with the firm.
Kennedy states he will keep his interest in such cases — a clear conflict of interest given the oversight of the agency he’s tapped to head.